Our Products

First Response® Malaria Antigen P.falciparum (HRP2) Card Test
First Response® Malaria Antigen P.falciparum (HRP2) Card Test
First Response® Malaria Antigen P.falciparum (HRP2) Card Test is intended to be performed by trained users (In either laboratory or point of care settings) as qualitative screening in vitro diagnostic test for detection of P. falciparum specific HRP2 antigen.
First Response® HIV 1-2.O Card Test (Version 2.0)
First Response® HIV 1-2.O Card Test (Version 2.0)
First Response® HIV 1-2.O Card Test (Ver. 2.0) is intended for use by healthcare professionals and qualified laboratory personnel. It is a rapid, qualitative screening, in vitro diagnostic test for detection of antibodies specific to HIV-1 (including Group O) and HIV-2 in human serum, plasma or venous and capillary whole blood.
First Response® HIV 1+2/Syphilis Combo Card Test
First Response® HIV 1+2/Syphilis Combo Card Test
First Response® HIV 1+2 / Syphilis Combo Card Test is intended for use by healthcare professionals and trained user. It is a rapid, qualitative screening, in vitro diagnostic test for the detection of antibodies (IgG & IgM) specific to HIV (type 1 & 2) and Treponema pallidum in human serum, plasma or venous and capillary whole blood.
First Response® Syphilis Anti TP Card Test
First Response® Syphilis Anti TP Card Test
First Response® Syphilis Anti-TP Card Test is intended for use by healthcare professionals and qualified laboratory personnel. It is a rapid, qualitative, screening, in vitro diagnostic test for the detection of antibodies of all classes specific to Treponema pallidum in human serum, plasma or Venous or capillary whole blood.
First Response® HCV Card Test
First Response® HCV Card Test
First Response® HCV Card Test is a chromatographic immunoassay for the qualitative detection of the antibodies against hepatitis C virus (HCV Ab) in human serum, plasma or whole blood (venous & capillary blood) specimens.

Welcome To Premier Medical

Summary:

Premier Medical Corporation Private Limited is one of the worldwide leaders in developing cost effective Point-of-Care rapid tests. These rapid diagnostic tests are both qualitative and semi-quantitative and include testing for infectious diseases through analysis of blood and other body fluids. These tests are marketed under the brand names First Response® and Sure Status®.

Nature of Business:

In March 1996, the company established its state-of-the-art manufacturing facility at Daman, India. Premier Medical Corporation Private Limited has set up an integrated manufacturing, marketing, and distribution operation. The company has established a strong distribution network throughout India, Africa, Europe, and South America, and has developed strategic co-marketing alliances with the leading medical companies. The company currently services diverse customer groups, i.e. health care professionals such as physicians, laboratories, hospitals, government health centers, distributors, and retailers.

LEARN MORE

Why Choose US?

Global Leader

Premier Medical Corporation has expertise in the development, manufacturing and distribution of affordable, high-quality, easy-to-use Rapid Diagnostic Tests. The company has a market presence of more than 20 years and has become a global leader in the field of in-vitro diagnostics. Our presence in African, European, Asian, and Middle East markets allows us to make a major impact on global healthcare.

Global Leader
Easy To Use Technology
Easy To Use Technology

  • Best-in-segment development of lateral flow assays (RDTs) with exceptional performance approvals from national and international evaluating laboratories. 
  • Dedicated R&D facilities with experienced and skilled workforce for development and validation of emerging technologies in the field of in-vitro diagnostics.
  • Constant updating of lateral flow platform with user friendliness and affordability in mind, all while maintaining the highest levels of quality.

Quality

The organization has developed a state-of-the-art manufacturing operation with Quality Management System compliance with ISO 13485:2016; WHO Prequalification Programme; and CE and other regulatory standards and requirements. Our track record with major public health procurement groups (including, but not limited to, WHO, The Global Fund, USAID, UNICEF, UNDP, UNFPA, PAHO, UNITAID, PATH, CHAI) speaks of our consistently high-quality lateral flow assays that have become synonymous with Premier Medical Corporation Private Limited.

Quality
Customer Satisfaction
Customer Satisfaction

While delivering the highest quality products with consistency and meeting customer specifications and timelines, we have developed a huge customer base consisting of the world’s leading public healthcare entities, government organizations and various funding agencies. Happy customers and end-users have become the greatest reward as we strive to improve global healthcare.

Years Experience
27
+

Years Experience

No of Product WHO PQed
7

No of Product WHO PQed

No of Products CE Marked
10

No of Products CE Marked

Countries Presence
100
+

Countries Presence

Latest News

0